Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
APOE and Parkinson disease are reported together in 5 articles.
Gene
APOE
- HGNC
- HGNC:613
46articles
46mentions
6variants with confirmed gene link
Most co-reported phenotypes (articles)
Alzheimer disease 18diabetes mellitus 6Parkinson disease 5dyslipidemia 5coronary artery disease 3stroke 3amyotrophic lateral sclerosis 2familial hypercholesterolemia 2
Reported variants (articles · ClinVar status)
Phenotype
Parkinson disease
280articles
280mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
5 records shown · first 60Multi-Transcriptome-Informed Network Pharmacology Reveals Novel Biomarkers and Therapeutic Candidates for Parkinson's Disease.
PMID 41465132 | PMCID PMC12732698 | DOI 10.3390/genes16121459 · Genes · 2025 · 11 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | APOE | “Then, protein-protein interaction (PPI) network analysis pinpointed seven top-ranked DEGs (GAPDH, PTEN, CCND1, APOE, ESR1, MAPK3/ERK1, and SNCA) as KGs or central modulators of PD pathogenesis.” | 0.98 | hgnc_dict_v1 |
| phenotype | Parkinson disease | “Multi-Transcriptome-Informed Network Pharmacology Reveals Novel Biomarkers and Therapeutic Candidates for Parkinson's Disease.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | GAPDH | “Then, protein-protein interaction (PPI) network analysis pinpointed seven top-ranked DEGs (GAPDH, PTEN, CCND1, APOE, ESR1, MAPK3/ERK1, and SNCA) as KGs or central modulators of PD pathogenesis.” | 0.98 | hgnc_dict_v1 |
| gene | PTEN | “Then, protein-protein interaction (PPI) network analysis pinpointed seven top-ranked DEGs (GAPDH, PTEN, CCND1, APOE, ESR1, MAPK3/ERK1, and SNCA) as KGs or central modulators of PD pathogenesis.” | 0.98 | hgnc_dict_v1 |
Molecular mechanisms and biomarkers in neurodegenerative disorders: a comprehensive review.
PMID 40138119 | DOI 10.1007/s11033-025-10463-w · Molecular biology reports · 2025 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | APOE | “The etiology and progression of these disorders are influenced by a complex interplay of environmental factors and genetic predispositions with specific genetic markers, such as mutations in the APOE and HTT genes, which play pivotal roles.” | 0.98 | hgnc_dict_v1 |
| phenotype | Parkinson disease | “Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Huntington's disease (HD), are significant global health challenges, owing to their profound impact on cognitive, motor, and behavioral functions.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | HTT | “The etiology and progression of these disorders are influenced by a complex interplay of environmental factors and genetic predispositions with specific genetic markers, such as mutations in the APOE and HTT genes, which play pivotal roles.” | 0.98 | hgnc_dict_v1 |
| phenotype | amyotrophic lateral sclerosis | “Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Huntington's disease (HD), are significant global health challenges, owing to their profound impact on cognitive, motor, and behavioral functions.” | 0.98 | phenotype_alias_lexicon_v2 |
Pharmacogenomics for neurodegenerative disorders - a focused review.
PMID 39759457 | PMCID PMC11695131 | DOI 10.3389/fphar.2024.1478964 · Frontiers in pharmacology · 2024 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | APOE | “Key genetic markers, such as the APOE ε4 allele in AD and the CYP2D6 polymorphisms in PD, are highlighted for their roles in modulating drug efficacy.” | 0.98 | hgnc_dict_v1 |
| phenotype | Parkinson disease | “Neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) are characterized by the progressive degeneration of neuronal structure and function, leading to severe cognitive and motor impairments.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | CYP2D6 | “Key genetic markers, such as the APOE ε4 allele in AD and the CYP2D6 polymorphisms in PD, are highlighted for their roles in modulating drug efficacy.” | 0.98 | hgnc_dict_v1 |
| phenotype | amyotrophic lateral sclerosis | “Neurodegenerative disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) are characterized by the progressive degeneration of neuronal structure and function, leading to severe cognitive and motor impairments.” | 0.98 | phenotype_alias_lexicon_v2 |
Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's disease.
PMID 35725575 | PMCID PMC9209443 | DOI 10.1038/s41531-022-00344-5 · NPJ Parkinson's disease · 2022 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | APOE | “Group differences in gait and balance between PD with and without GBA variants were assessed with linear regression, adjusting for age, gender, clinical testing site, disease duration, and apolipoprotein E (APOE) ɛ4 status.” | 0.98 | hgnc_dict_v1 |
| phenotype | Parkinson disease | “Cognition as a mediator for gait and balance impairments in GBA-related Parkinson's disease.” | 0.93 | phenotype_alias_lexicon_v2 |
| variant | E326K | “We aimed to determine differences in gait and balance impairments in those with and without GBA variants (mutation carriers and E326K polymorphism) and explore direct and indirect effects of GBA status on gait, balance, and cognition.” | 0.82 | literature_variant_regex_v2 |
Apolipoprotein E polymorphism is associated with susceptibility to schizophrenia among Saudis.
PMID 26322100 | PMCID PMC4548040 | DOI 10.5114/aoms.2015.53308 · Archives of medical science : AMS · 2015 · 3 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | APOE | “INTRODUCTION: Apolipoprotein E (APOE) genotypes influence the phenotype of several neurodegenerative disorders including Alzheimer's and Parkinson disease and may affect schizophrenia pathogenesis.” | 0.98 | hgnc_dict_v1 |
| phenotype | Parkinson disease | “INTRODUCTION: Apolipoprotein E (APOE) genotypes influence the phenotype of several neurodegenerative disorders including Alzheimer's and Parkinson disease and may affect schizophrenia pathogenesis.” | 0.98 | phenotype_alias_lexicon_v2 |
| population | Saudi Arabia | “This study was undertaken to determine the association between APOE gene polymorphisms and schizophrenia in the Saudi population. MATERIAL AND METHODS: APOE allele and genotype frequencies were studied in 380 Saudi subjects including schizophrenia patients and matched controls using polymerase chain reaction (PCR) and reverse-hybridization techniques.” | 0.95 | saudi_context_rules_v1 |